Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 5

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISSN: 2451-8905 (Print)
ISSN: 2215-0803 (Online)
ISBN: 978-981-14-0514-3 (Print)
ISBN: 978-981-14-0515-0 (Online)
Year of Publication: 2019
DOI: 10.2174/97898114051501190501

Introduction

Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.

The fifth volume of the book features reviews on biochemical inhibitors (second-generation protein kinase Inhibitors, histone deacetylase inhibitors, immune checkpoint inhibitors, EGFR Tyrosine Kinase inhibitors, non-coding RNAs), apoptosis, and physical exercise therapy for cancer patients undergoing chemotherapy. The treatment strategies in this volume cover cancers such as acute myeloid leukemia, gastrointestinal cancer, breast cancer and lung cancer.

Preface

- Pp. i
Atta-ur-Rahman
Download Free

List of Contributors

- Pp. ii
Atta-ur-Rahman
Download Free

Second-Generation Protein Kinase Inhibitor – A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia

- Pp. 1-21 (21)
Xavier Thomas and Etienne Paubelle

PDF Price: $30

View Abstract Purchase Chapter

Physical Exercise for Cancer Patients Treated with Chemotherapy

- Pp. 22-49 (28)
Shinichiro Morishita, Atsuhiro Tsubaki and Jack B. Fu

PDF Price: $30

View Abstract Purchase Chapter

Cancer Immune Evasion in Gastrointestinal Cancer: Can this be Overcome by Combination of Histone Deacetylase and Immune Checkpoint Inhibitors?

- Pp. 50-84 (35)
Yuequan Shi, Onyinyechi Duru, Zifang Zou and David Kerr

PDF Price: $30

View Abstract Purchase Chapter

Long Non-Coding RNAs in Cancer Progression: Implication for Anti-Cancer Therapy

- Pp. 85-112 (28)
Chang Gong, Zihao Liu, Andrew J. Sanders and Wen G. Jiang

PDF Price: $30

View Abstract Purchase Chapter

Ros-Mediated Induction of Apoptosis in Breast Cancer Cells

- Pp. 113-121 (9)
Işıl Yıldırım

PDF Price: $30

View Abstract Purchase Chapter

Generations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Battle against Drug Resistant Lung Cancer

- Pp. 122-165 (44)
Kenneth K.W. To and Wing-Sum Tong

PDF Price: $30

View Abstract Purchase Chapter

Subject Index

- Pp. 166-174 (9)
Atta-ur-Rahman
Download Free

RELATED BOOKS

.Frontiers in Clinical Drug Research - Anti-Cancer Agents.
.Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine.
.Current Advances in Breast Cancer Research: A Molecular Approach.
.Avastin and Malignant Gliomas .